都相信我的话 发表于 2025-3-28 16:52:04
Regulation of IL-4 and IL-5 Secretion by Histamine and PGE2,d by the culture of peripheral blood lymphocytes from atopic individuals in the presence of ragweed or dustmite antigen. The cloned TH. lymphocytes were then stimulated with PMA (10 ng/ml) and a-CD3 (50 ng/ml) in the presence and absence of histamine (10.-10.M) and PGE. (10.10.M) for 48 hours. Other处理 发表于 2025-3-28 20:01:48
http://reply.papertrans.cn/47/4622/462108/462108_42.png中止 发表于 2025-3-29 02:34:37
Substance P Mediated Stimulation of Cytokine Levels in Cultured Murine Bone Marrow Stromal Cells,eripheral immune system. More recently, SP has been reported to have stimulatory activity on human bone marrow cells ., and this activity was dependent on the presence of an adherent layer of cells. The . adherent layer represents the stromal cells of the marrow. In this study, we directly addressed联合 发表于 2025-3-29 06:15:34
Malaria Transmission-Blocking Immunity,was not feasible, attention turned to control and newer approaches to combat this major cause of human misery. According to published estimates, malaria parasites annually infect 250 to 300 million people, cause 100-120 million clinical cases, and kill 1 to 2 million people. Including recent estimat不自然 发表于 2025-3-29 11:05:21
Liposomal Vaccines,peptide synthesis. These new technologies opened the door to development of vaccines effective against newly emerging pathogens and even proteins or antigens that cause diseases of noninfectious origin. However, realization of the potential of subunit or peptide vaccines has been hampered by fundamedragon 发表于 2025-3-29 14:37:40
http://reply.papertrans.cn/47/4622/462108/462108_46.png去才蔑视 发表于 2025-3-29 18:38:06
http://reply.papertrans.cn/47/4622/462108/462108_47.png表脸 发表于 2025-3-29 23:45:55
http://reply.papertrans.cn/47/4622/462108/462108_48.pngcataract 发表于 2025-3-30 03:04:25
http://reply.papertrans.cn/47/4622/462108/462108_49.png剥削 发表于 2025-3-30 04:32:33
Intravenous Immunoglobins (IVIGS) to Prevent and Treat Infectious Diseases,therapies that would supplement conventional antibiotics and supportive care. The impetus for such treatments was driven in part by the suboptimal clinical results obtained with conventional care in many clinical conditions, such as sepsis where a 30-50% mortality persists despite the introduction o